A Facile Synthesis of Raltegravir Potassium—An HIV Integrase Inhibitor

A facile, cost‐effective, and commercially viable synthesis of Raltegravir Potassium ( 1 ) has been developed from 2‐(1‐amino‐1‐methyl‐ethyl)‐N‐[(4‐fluorophenyl)methyl]‐1,6‐dihydro‐5‐hydroxy‐1‐methyl‐6‐oxo‐4‐pyrimidinecarboxamide ( 9 ) with high purity and in good yields. In addition, a new approach for the synthesis of key amine intermediate ( 9 ) of Raltegravir Potassium ( 1 ) from commercially available 2‐amino‐2‐methylpropanenitrile hydrochloride ( 2 ) is also described. The key features of the synthesis are fewer synthetic steps, employing the inexpensive reagents and eco‐friendly.     

Synthesis of Barleriaquinones-I & II

Synthesis of two naturally occurring anthraquinones, Barleriaquinone-I (BQ-I) and Barleriaquinone-II (BQ-II) is achieved from commercially available naphthalene-1,5-diol. The anthraquinone core is constructed by utilizing simultaneous Heck and cross coupling reaction as the key step.     

A new stability indicating reverse phase high performance liquid chromatography method for the determination of enantiomeric purity of a DPP‐4 inhibitor drug linagliptin

A simple, sensitive, and stability indicating isocratic reverse phase high performance liquid chromatography method has been developed, optimized and validated for the separation and quantification of S‐enantiomer in linagliptin (R‐enantiomer) drug substance. Enantiomeric separation was achieved on a Cellulose tris(4‐chloro‐3‐methylphenylcarbamate) stationary phase. Mobile phase consists of aqueous diammonium hydrogen phosphate buffer and acetonitrile in the ratio of 35:65 v/v. Isocratic elution was performed at a flow rate of 1.0 mL/min, the column oven temperature was set at 40°C and detection was at 226 nm. The resolution between R and S enantiomers is found to be more than 4.0. The impact of mobile phase composition, pH of buffer and temperature on the resolution has been studied. The detector response is found to be linear over the concentration range of 0.17–1.7 μg/mL. LOD and LOQ levels of S‐enantiomer are found to be 0.057 and 0.172 μg/mL respectively. The recovery of S‐enantiomer is 99.8% w/w. The proposed method is validated for specificity, precision, linearity, accuracy and robustness.     

Synthesis and characterization of potential impurities of Vigabatrin-An anti epileptic drug

The present work describes the synthesis and characterization of four potential impurities of Vigabatrin (1 Grant, S. M.; Heel, R. C. A Review of Its Pharmacodynamic and Pharmacokinetic Properties, and Therapeutic Potential in Epilepsy and Disorders of Motor Control. Drugs. 1991, 41, 889-926. doi:10.2165/00003495-199141060-00007[Crossref], [PubMed], [Web of Science ®] , [Google Scholar]) namely 2-(2-aminobut-3-enyl)malonic acid (2 Impurities in New Drug Substances Q3A (R2): 2006. www.ich.org/products/guidelines/quality/article/quality-guidelines.html (accessed Aug 16, 2018). [Google Scholar]) (Vigabatrin USP impurity-E), 2-(2-oxo-5-vinylpyrrolidin-1-yl)acetic acid (3 Validation of Analytical Procedures: Text and Methodology Q2 (R1): 2006. www.ich.org/products/guidelines/quality/article/quality-guidelines.html (accessed Aug 16, 2018). [Google Scholar]) (USP Tablets impurity), 4-aminohexanoic acid (4 Maurice, W. G.; Gerard, J. L. 2-Pyrrolidinone Compounds and Processes for Making Same. U.S. Patent 4,235,778, November 25, 1980. [Google Scholar]) and 2,2′-oxo-5,5′-bispyrrolidinyl ether (5 Marie-Christine, D.; Bienayme, H.; Popowycz, F.; Lemaire M. Process for Preparing 4-Amino-5-hexenoic acid From Succinimide. E.P. Patent 2,537,827 A1, June 26, 2011. [Google Scholar]). Compound 4 is a possible process related impurity of 1 where as compound 5 is a process related impurity of 5-ethoxy-2-pyrrolinone (16). All these impurities have a significant impact on the quality of the drug product. This work is extremely useful for generic pharmaceutical industry.     

Resolution of racemic Vigabatrin using tartaric acid

An efficient and simple resolution methodology for the preparation of (S)- and (R)-Vigabatrin has been developed. In addition, a method of preparation for the novel compounds Vigabatrin-l-tartarate and Vigabatrin-d-tartarate is also described. The title compounds have been synthesized via resolution of Vigabatrin using commercially available l-(+)- and d-(?)-tartaric acids respectively.     

Synthesis,biological evaluation and molecular docking studies of novel 2-(2-cyanophenyl)-N-phenylacetamide derivatives

A series of novel 2-(2-cyanophenyl)-N-phenylacetamide derivatives 3(a-u) were designed and synthesized via selective amidation of methyl-2-(2-cyanophenyl)acetates over amidine formation by using AlMe₃ as catalyst in good yields. All the newly synthesized derivatives were well characterized by ¹H NMR, ¹³C NMR, FTIR and HRMS spectral techniques. All the synthesized title compounds were evaluated for their in vitro anticancer activity against three cancer cell lines. Among all compounds, 3i (IC₅₀?=?1.20 μM, IC₅₀?=?1.10 μM), 3j (IC₅₀?=?0.11 μM, IC₅₀?=?0.18 μM), 3o (IC₅₀?=?0.98 μM, IC₅₀?=?2.76 μM) showed excellent inhibitory activity than the standard Etoposide (IC₅₀?=?2.11 μM, IC₅₀?=?3.08 μM) against MCF-7 and A-549 cell lines, respectively. Docking analysis of all the compounds with the human topoisomerase II revealed that the compound 3j fitted well in the active site pocket, showing the best docking score of 158.072 kcal/mol.

     

Microwave assisted one pot synthesis of 2-ethylamino benzimidazole,benzoxazole and benzothiazole derivatives

A rapid and efficient one-pot method for the synthesis of 2-ethylamino benzimidazole, benzoxazole, and benzothiazole derivatives has been described. The reaction of o-phenylenediamines or o-aminophenols or 2-mercaptoanilines with EDC.HCl under microwave irradiation afforded the corresponding 2-ethylamino benzimidazole, benzoxazole and benzothiazole derivatives in excellent yields.     

An alternative total synthesis of Patulolide A

A new total synthesis of [R]‐Patulolide A from readily available (R)‐propylene epoxide obtained using the asymmetric synthetic approach is reported. The key reactions involved are ozonolysis and Yamaguchi macrolactonization, resulting in the ring system.     

Design and applications of new phosphine-free tetradentate Pd-catalyst: Regioselective C–H activation on 1-substituted 1,2,3-triazoles and indoles(NH-Free)

This article describes the synthesis of a new phosphine free tetradentate Pd catalyst using dl-2,3-diaminopropionic acid. The complex was characterized by Mass, IR, and ¹H NMR. The catalyst is air stable at room temperature and non-hygroscopic. Application of this new catalyst to regioselective C–H activation on 1-substituted 1,2,3-triazole and indoles with aryl iodides to get corresponding C-5 and C-2 arylated products with satisfactory yields. All the products were characterized by spectroscopic studies.